Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears on the page, replacing the previous v3.4.1. No substantive study content changes were detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:53:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision shows a minor backend update from v3.4.0 to v3.4.1 with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:28:40.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    The page revision changed from v3.4.0 to v3.4.1, with no observed changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:26:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: updated from v3.3.3 to v3.3.4; no user-facing changes observed in the study details, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:58:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Maryland, Michigan, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Virginia, Washington, West Virginia). Updated the revision to v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T14:49:31.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate that publications are automatically filled from PubMed and may not be about the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:14.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.